InvestorsHub Logo

BonelessCat

10/04/21 10:21 AM

#377186 RE: sunspotter #377181

Yet, if you’re vaccinated with AZ, Pfizer, J&J or Moderna, you are 3% as likely to be hospitalized. Yet, 40% of America will take a drug that reduces hospitalization only slightly or in MRK’s case 50%. Go figure.

LIVED

10/04/21 10:46 AM

#377192 RE: sunspotter #377181

"MRK drug is useless."

As usual, Merck will concoct a way to profit from a useless drug...even AstraZenaca was dumped on poorer countries.

thefamilyman

10/04/21 10:48 AM

#377193 RE: sunspotter #377181

It’s a 2% chance of dying of Covid. So what are the increased chances of dying of cancer over the next 5 years? 10 years? Oh that’s right, they haven’t done that study yet have they? I guess they want to get that EUA and the limits on liability that comes with it. That way they can use the American public as their guinea pigs while being protected from liability for killing and/or debilitating people with a drug that they KNOW is mutagenic.

Sunspotter said,

…two out of every hundred patients in the placebo arm died, which is by no means negligible.



I don’t see it as a win. I see it as a big pharmaceutical company trying to take advantage of the pandemic and game the system at the expense of people suffering from Covid. A drug with proven mutagenic properties should not be approved (even under an EUA) without extensive (independently verified) multi-year testing. I see a known risk of 2% as acceptable when compared to the unknowns presented by molnupiravir.

Sunspotter said,

In both health terms and in health economic terms, this is a real win…

KMBJN

10/04/21 2:22 PM

#377228 RE: sunspotter #377181

If you contract mild-to-moderate COVID-19, then you are half as likely to be hospitalised if you take the Merck drug than if you don't.



Not quite. Only half as likely if at high risk, which could be a decent number of people, but not 100%.